LC
Lindbrook Capital’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $4.01M | Buy |
8,063
+345
| +4% | +$172K | 0.37% | 45 |
|
|
2024
Q4 | $4.02M | Sell |
7,718
-91
| -1% | -$47.3K | 0.36% | 41 |
|
|
2024
Q3 | $4.83M | Sell |
7,809
-352
| -4% | -$218K | 0.43% | 36 |
|
|
2024
Q2 | $4.51M | Sell |
8,161
-1,130
| -12% | -$625K | 0.42% | 37 |
|
|
2024
Q1 | $5.4M | Buy |
9,291
+126
| +1% | +$73.2K | 0.51% | 36 |
|
|
2023
Q4 | $4.86M | Buy |
9,165
+130
| +1% | +$69K | 0.49% | 39 |
|
|
2023
Q3 | $4.57M | Buy |
9,035
+199
| +2% | +$101K | 0.51% | 34 |
|
|
2023
Q2 | $4.61M | Buy |
8,836
+214
| +2% | +$112K | 0.49% | 36 |
|
|
2023
Q1 | $4.97M | Buy |
8,622
+238
| +3% | +$137K | 0.58% | 28 |
|
|
2022
Q4 | $4.62M | Buy |
8,384
+7,473
| +820% | +$4.12M | 0.57% | 27 |
|
|
2022
Q3 | $462K | Buy |
911
+106
| +13% | +$53.8K | 0.08% | 154 |
|
|
2022
Q2 | $437K | Buy |
805
+28
| +4% | +$15.2K | 0.07% | 167 |
|
|
2022
Q1 | $459K | Sell |
777
-29
| -4% | -$17.1K | 0.07% | 172 |
|
|
2021
Q4 | $538K | Buy |
806
+206
| +34% | +$138K | 0.08% | 153 |
|
|
2021
Q3 | $343K | Buy |
600
+16
| +3% | +$9.15K | 0.09% | 94 |
|
|
2021
Q2 | $295K | Buy |
584
+16
| +3% | +$8.08K | 0.07% | 126 |
|
|
2021
Q1 | $259K | Buy |
568
+30
| +6% | +$13.7K | 0.06% | 130 |
|
|
2020
Q4 | $251K | Sell |
538
-14
| -3% | -$6.53K | 0.06% | 120 |
|
|
2020
Q3 | $244K | Sell |
552
-11
| -2% | -$4.86K | 0.07% | 109 |
|
|
2020
Q2 | $204K | Sell |
563
-11
| -2% | -$3.99K | 0.06% | 121 |
|
|
2020
Q1 | $163K | Sell |
574
-145
| -20% | -$41.2K | 0.06% | 122 |
|
|
2019
Q4 | $234K | Buy |
719
+22
| +3% | +$7.16K | 0.08% | 121 |
|
|
2019
Q3 | $203K | Sell |
697
-14
| -2% | -$4.08K | 0.08% | 132 |
|
|
2019
Q2 | $208K | Buy |
711
+13
| +2% | +$3.8K | 0.08% | 129 |
|
|
2019
Q1 | $191K | Buy |
698
+120
| +21% | +$32.8K | 0.08% | 134 |
|
|
2018
Q4 | $129K | Buy |
+578
| New | +$129K | 0.06% | 159 |
|